EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Spleen Cytokines Against Inflammatory Bowel Disease
Over one hundred years ago at the University of Toronto Frederick Banting Charles Best and James Collip extracted protein insulin from the pancreas that saved the lives of millions of diabetics since then It is possible that the proteins extracted from the spleen can also help people with inflammatory bowel disease IBD
Building Resilient Pharma Supply Chains to Strengthen Patient Care
The failure to deliver a temperaturesensitive biologic or a critical maintenance drug on time is becoming a patient outcome crisis not just an operational inefficiency By fortifying our global logistics networks we proactively safeguard the availability of lifesaving therapies and essential healthcare supplies securing the healthcare industrys central promise to global health This strategic impera...
The Impact of AI and Machine Learning on Drug Discovery
Now and then an industry hits a point where the old ways no matter how trusted start to feel a bit like trying to run a marathon in hiking boots Drug discovery is in that spot For decades pharmaceutical RD leaned heavily on long painstaking experiments and the occasional stroke of luck Entire teams would spend years nudging molecules around waiting for a hint that something might work After all th...
Navigating the Pharma Market: Strategies for Successful Pharmaceutical Sales
Navigating the pharmaceutical market requires a blend of strategic planning industry knowledge and effective communication skills In this guide well explore key strategies for successful pharmaceutical sales in a way thats easy to understand
Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide
The pharmaceutical sector is changing radically as manufacturers do not rely on the past and dataintensive processes The vision of paperless pharma manufacturing is not a dream anymore it is a strategy based on the pressure of the regulators the complexity of operations and the need to accomplish faster and with accuracy production The center of this change is the digital pharma manufacturing and...
Bridging the Biotech–Pharma Innovation Gap Through Strategic Partnerships
Europe has never lacked ideas Its universities translational institutes and spinout companies consistently generate novel biology from geneediting tools to antibody engineering and mRNA platforms What the continent has struggled with is the journey that follows turning a validated mechanism into an approved reimbursed and reliably manufactured medicine That journey demands capital regulatory fluen...
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Building Resilient Pharma Supply Chains to Strengthen Patient Care
Lesley Barton
In the complex, global ecosystem of pharmaceutical manufacturing and distribution, the supply chain is no longer merely a logistical function but a direct extension of clinical efficacy. For C-level e...
-
2
The Impact of AI and Machine Learning on Drug Discovery
Satyajit Shinde
Artificial intelligence (AI) and machine learning (ML) are revolutionising drug discovery by dramatically accelerating the identification and development of new therapies. These technologies analyse v...
-
3
Navigating the Pharma Market: Strategies for Successful Pharmaceutical Sales
Kate Williamson
This comprehensive guide explores strategies for successful pharmaceutical sales, covering key players, targeted marketing, relationship building, data-driven insights, compliance, value-based selling...
-
4
Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide
Kate Williamson
This article discusses how paperless pharma production is achieved to realize complete digital maturity, through automation, compliance-sourced software and integrated digital systems. It shows the ad...
-
5
Bridging the Biotech–Pharma Innovation Gap Through Strategic Partnerships
Lakshmi
Europe produces world-class biotechnology science, yet too many promising molecules stall between discovery and the patient. This article examines why the biotech–pharma innovation gap persists,...
press releases Read more...
Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
Jupiter Neurosciences Inc NASDAQ JUNS a clinicalstage biopharmaceutical company developing investigational therapies for neurodegenerative diseases today announced that the first patient has been dosed
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
Telix Pharmaceuticals Limited today announces that the first patients in the United States US have been dosed with Pixclara floretyrosine F or FFET its FDAapproved amino acid positron emission
VTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
VTv Therapeutics Inc Nasdaq VTVT a latestage biopharmaceutical company advancing cadisegliatin a novel oral investigational therapy for type diabetes TD today announced that the Company has completed
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
Crescent Biopharma Inc Crescent or the Company Nasdaq CBIO a clinicalstage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients
Events Read more...
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026Pharma Manufacturing & Automation Convention 2026
Novotel Hyderabad Airport, Ind...
LATEST NEWS Read more...
Sensible Biotechnologies Secures $47 Million to Advance Cell-Based mRNA Platform
Sensible Biotechnologies has secured million in financing to advance and scale its platform for producing naturally modified messenger RNA mRNA medicines The funding includes a Series A round
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
PacBio and TychoBio have entered into a collaboration to generate fulllength RNA data for training artificial intelligence AI models designed to support RNA therapy development for rare diseases
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialise EXPAREL® in the European Union and UK
Pacira BioSciences has entered into a strategic agreement with Molteni Farmaceutici to expand access to EXPAREL bupivacaine liposome injectable suspension for postsurgical pain management across selected European markets
ORIC Pharmaceuticals and Cancer Research UK Partner to Advance CIP2A-Targeted Cancer Therapy
ORIC Pharmaceuticals has entered into an agreement with Cancer Research UK to advance ORIC a potential firstinclass therapy targeting Cancerous Inhibitor of PPA CIPA into clinical development
AstraZeneca Opens New Global R&D Centre in Kendall Square, Cambridge, Massachusetts
AstraZeneca has opened a new global strategic research and development RD centre in Kendall Square Cambridge Massachusetts expanding its presence in the region and strengthening its global research capabilities
Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development
Quotient Sciences and Acesion Pharma have announced a collaboration to use AIenhanced formulation development to support Acesions earlystage pipeline of smallmolecule treatments for atrial fibrillation



